Joanna Wdzieczak-Bakala Selected Research

aspartyllysine

12/2009	Elevated plasma levels of the angiogenic tetrapeptide acetyl-ser-asp-lys-pro are found in some patients with hematologic malignancies.
9/2006	Evidence for an association of high levels of endogenous Acetyl-Ser-Asp-Lys-Pro, a potent mediator of angiogenesis, with acute myeloid leukemia development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna Wdzieczak-Bakala Research Topics

Disease

12	Neoplasms (Cancer) 01/2018 - 02/2006
3	Hematologic Neoplasms (Hematological Malignancy) 04/2010 - 02/2006
2	Carcinogenesis 10/2015 - 05/2010
2	Goiter 09/2008 - 02/2006
1	Tuberous Sclerosis (Bourneville's Disease) 10/2015
1	Leiomyoma (Uterine Fibroids) 10/2015
1	Dehydration (Water Stress) 02/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2010
1	Multiple Myeloma 05/2010
1	Papillary Carcinoma 09/2008
1	Prostatic Neoplasms (Prostate Cancer) 09/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2006
1	Leukemia 09/2006
1	Wounds and Injuries (Trauma) 05/2006
1	Necrosis 05/2006
1	Ischemia 04/2006

Drug/Important Bio-Agent (IBA)

7	goralatideIBA 01/2013 - 02/2006
3	TubulinIBA 04/2013 - 06/2008
2	Peptides (Polypeptides)IBA 01/2013 - 02/2006
2	aspartyllysineIBA 12/2009 - 09/2006
1	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2018
1	MTOR InhibitorsIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	trans-sodium crocetinate (crocetin)IBA 10/2015
1	Sirolimus (Rapamycin)FDA Link 10/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015
1	GangliosidesIBA 03/2014
1	poly(ethylene glycol)-block-poly(styrene)IBA 02/2013
1	ErianinIBA 03/2011
1	Cyclin D1IBA 05/2010
1	CyclinsIBA 05/2010
1	thymosin beta(4)IBA 04/2010
1	ProdrugsIBA 11/2009

Therapy/Procedure

1	Therapeutics 01/2018
1	Injections 05/2006
1	Ligation 04/2006